Home
Careers
Conferences
Directory
Genes
InDepth
Marketing
News
Reports
Videos
Search
Contact
Items Ordered:
Cart Value:
New Products:
1.
Pharmaceutical Market Trends, 2008 - 2012: key market forecasts & growth opportunities
2.
Top-10 Biotech Companies - Market Outlook, 2008-2023
3.
Competitor Analysis: Janus Kinase (JAK) Inhibitors
4.
Enzyme Replacement & Enhancement Therapies (ERT)
5.
The Clinical Laboratory Services Market (Growth Opportunities, Competitive Analysis and Competitor Profiles)
6.
The Cancer Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
7.
Protein Therapeutics Markets
8.
European Clinical Trial Site Options: An Insiders Analysis Overview
9.
Quality for Biologics
10.
Mammography World Markets
Best Sellers:
1.
Contract Research Annual Review 2008
2.
The Pharmaceutical Wholesale and Distribution Industry Outlook and Analysis 2008
3.
The World OTC Pharmaceutical Market Analysis and Forecasts, 2008-2023
4.
Top Companies and Products in the RNA/DNA Therapy Products Market Forecasts The challenge of turning technology into therapy
5.
Orthopedics - Global Industry Guide
6.
Competitor Analysis: c-MET/HGF Inhibitors
7.
Competitor Analysis: Alzheimers Disease Antibodies
Good Manufacturing Practices 3rd Edition
A Guide to Good Manufacturing Practices 3rd Edition
By Alex D. Kanarek, Ph.D.
Published: July, 2006
Newly Revised to Include the Latest FDA Regulations
Scope of Guide
D&MD's updated Good Manufacturing Practices professional development guide provides pharmaceutical and biological companies of all sizes with assistance in regulatory compliance. The guide examines the new FDA Guidance for Industry documents and a new amendment covering an exemption for investigational drugs in Phase 1 studies. The guide is addressed particularly to smaller sized companies, perhaps those with their first new drug, working on this extra challenge to their capabilities.
Analyzing the contents of the latest versions of the GMP rules laid down by the USA, Canada and Japan, ICH, the EC and WHO, this guide provides pharmaceutical and biological companies of all sizes with assistance in compliance with these rules. The guide is addressed particularly to smaller sized companies, perhaps those with their first new drug, working on this extra challenge to their capabilities.
Questions Answered
> What drug products are covered by the cGMP regulations?
> At what stage in a drug's development do the cGMP regulations become effective?
> How do we apply these regulations to our manufacturing operations?
> How do we ensure we will pass a cGMP inspection?
Target Audience
This guide will prove beneficial to the following professionals involved in Pharmaceutical, Biopharmaceutical and Biological development and manufacturing:
> Heads of Manufacturing
> QA, QC
> Regulatory Affairs
> Product & Process Development Scientists
> Manufacturing Supervisory Staff
> QA Auditing Staff
> Validation Experts
> GMP Trainers
Jul-06 Pages 423 PDF Format
The Author
Price: $895.00 / GBP590.70
Good Manufacturing Practices 3rd Edition
A Guide to Good Manufacturing Practices 3rd Edition
By Alex D. Kanarek, Ph.D.
Published: July, 2006
Newly Revised to Include the Latest FDA Regulations
Scope of Guide
D&MD's updated Good Manufacturing Practices professional development guide provides pharmaceutical and biological companies of all sizes with assistance in regulatory compliance. The guide examines the new FDA Guidance for Industry documents and a new amendment covering an exemption for investigational drugs in Phase 1 studies. The guide is addressed particularly to smaller sized companies, perhaps those with their first new drug, working on this extra challenge to their capabilities.
Analyzing the contents of the latest versions of the GMP rules laid down by the USA, Canada and Japan, ICH, the EC and WHO, this guide provides pharmaceutical and biological companies of all sizes with assistance in compliance with these rules. The guide is addressed particularly to smaller sized companies, perhaps those with their first new drug, working on this extra challenge to their capabilities.
Questions Answered
> What drug products are covered by the cGMP regulations?
> At what stage in a drug's development do the cGMP regulations become effective?
> How do we apply these regulations to our manufacturing operations?
> How do we ensure we will pass a cGMP inspection?
Target Audience
This guide will prove beneficial to the following professionals involved in Pharmaceutical, Biopharmaceutical and Biological development and manufacturing:
> Heads of Manufacturing
> QA, QC
> Regulatory Affairs
> Product & Process Development Scientists
> Manufacturing Supervisory Staff
> QA Auditing Staff
> Validation Experts
> GMP Trainers
Jul-06 Pages 423 PDF Format
The Author
Price: $895.00 / GBP590.70
Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.